Figure 2

Antibodies to malaria antigens at 36 weeks categorized by supplementation type. (A) Antibodies to variant surface antigens expressed by placental-binding and non-placental-binding parasite isolates. (B) Antibodies to merozoite antigens and schizont extract. Data presented as box plots with the Y axis representing antibodies as a percentage of the positive control. The whiskers denote the 10^th and the 90^th percentiles with outliers. Mann Whitney U test performed for antibody comparisons between supplementation groups LNS versus IFA and LNS versus MMN. N = 1,009.